287 related articles for article (PubMed ID: 38177560)
1. Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma.
Wheless M; Agarwal R; Goff L; Lockney N; Padmanabhan C; Heumann T
Curr Treat Options Oncol; 2024 Jan; 25(1):127-160. PubMed ID: 38177560
[TBL] [Abstract][Full Text] [Related]
2. Cholangiocellular Carcinoma.
Vogel A; Saborowski A
Digestion; 2017; 95(3):181-185. PubMed ID: 28288474
[TBL] [Abstract][Full Text] [Related]
3. Future directions in the treatment of cholangiocarcinoma.
Zhu AX
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):355-61. PubMed ID: 25966434
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostics and treatment of cholangiocarcinoma].
Mantel HT; Verdonk RC; van Dullemen HM; Gietema JA; Slooff MJ; Porte RJ
Ned Tijdschr Geneeskd; 2008 May; 152(18):1037-41. PubMed ID: 18547024
[TBL] [Abstract][Full Text] [Related]
5. Revolutionizing anti-HER2 therapies for extrahepatic cholangiocarcinoma and gallbladder cancer: Current advancements and future perspectives.
Ten Haaft BH; Pedregal M; Prato J; Klümpen HJ; Moreno V; Lamarca A
Eur J Cancer; 2024 Mar; 199():113564. PubMed ID: 38266541
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review.
Rizzo A; Brandi G
Cancer Treat Res Commun; 2021; 27():100354. PubMed ID: 33756174
[TBL] [Abstract][Full Text] [Related]
7. How I treat biliary tract cancer.
Lamarca A; Edeline J; Goyal L
ESMO Open; 2022 Feb; 7(1):100378. PubMed ID: 35032765
[TBL] [Abstract][Full Text] [Related]
8. Integrating cytotoxic, targeted and immune therapies for cholangiocarcinoma.
Merters J; Lamarca A
J Hepatol; 2023 Mar; 78(3):652-657. PubMed ID: 36400328
[TBL] [Abstract][Full Text] [Related]
9. The state of therapy modalities in clinic for biliary tract cancer.
Chen W; Hu Z; Song J; Wu Y; Zhang B; Zhang L
Front Biosci (Landmark Ed); 2022 Jun; 27(6):185. PubMed ID: 35748261
[TBL] [Abstract][Full Text] [Related]
10. Landmark survival analysis and impact of anatomic site of origin in prospective clinical trials of biliary tract cancer.
McNamara MG; Lopes A; Wasan H; Malka D; Goldstein D; Shannon J; Okusaka T; Knox JJ; Wagner AD; André T; Cunningham D; Moehler M; Jensen LH; Koeberle D; Bekaii-Saab T; Bridgewater J; Valle JW
J Hepatol; 2020 Nov; 73(5):1109-1117. PubMed ID: 32446715
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Abdel-Rahman O; Elsayed Z; Elhalawani H
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
[TBL] [Abstract][Full Text] [Related]
12. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma.
Esnaola NF; Meyer JE; Karachristos A; Maranki JL; Camp ER; Denlinger CS
Cancer; 2016 May; 122(9):1349-69. PubMed ID: 26799932
[TBL] [Abstract][Full Text] [Related]
13. Clinical diagnosis and staging of cholangiocarcinoma.
Blechacz B; Komuta M; Roskams T; Gores GJ
Nat Rev Gastroenterol Hepatol; 2011 Aug; 8(9):512-22. PubMed ID: 21808282
[TBL] [Abstract][Full Text] [Related]
14. The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment.
Demols A; Maréchal R; Devière J; Van Laethem JL
Best Pract Res Clin Gastroenterol; 2007; 21(6):1015-29. PubMed ID: 18070701
[TBL] [Abstract][Full Text] [Related]
15. Cholangiocarcinoma: Diagnosis and Management.
Buckholz AP; Brown RS
Clin Liver Dis; 2020 Aug; 24(3):421-436. PubMed ID: 32620281
[TBL] [Abstract][Full Text] [Related]
16. Systemic treatment of advanced or recurrent biliary tract cancer.
Zhang W; Zhou H; Wang Y; Zhang Z; Cao G; Song T; Zhang T; Li Q
Biosci Trends; 2020 Nov; 14(5):328-341. PubMed ID: 32830166
[TBL] [Abstract][Full Text] [Related]
17. [Malignant lesions of the extrahepatic biliary system].
Litchinko A; Peloso A; Toso C; Compagnon P
Rev Med Suisse; 2022 Jun; 18(786):1210-1217. PubMed ID: 35703864
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic relevance of targeted sequencing in management of patients with advanced biliary tract cancer: DNA damage repair gene mutations as a predictive biomarker.
Chae H; Kim D; Yoo C; Kim KP; Jeong JH; Chang HM; Lee SS; Park DH; Song TJ; Hwang S; Kim KH; Song GW; Ahn CS; Lee JH; Hwang DW; Kim SC; Jang SJ; Hong SM; Kim TW; Ryoo BY
Eur J Cancer; 2019 Oct; 120():31-39. PubMed ID: 31476489
[TBL] [Abstract][Full Text] [Related]
19. Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics.
Nagino M
J Gastroenterol; 2012 Nov; 47(11):1165-76. PubMed ID: 22847554
[TBL] [Abstract][Full Text] [Related]
20. Exploring Molecular Mechanisms in the Second-Line Treatment of Biliary Tract Malignant Tumors.
Liu Q; Zhang P; Li Q
Discov Med; 2024 Jan; 36(180):48-60. PubMed ID: 38273745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]